The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
22.1K
2023
Research & development expense
The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.
883.87K
2024
Total assets
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
79.47K
2024
Total liabilities
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
36.3M
2024
Total equity
Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
-36.22M
2024
Net cash provided by financing activities
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.